Obizur (antihaemophilic factor porcine factor viii:c susoctocog): Reviews and patient testimonials


/static/themes-v3/default/images/default/opinion/traitement/intro-mobile.jpg?1720004028

Back Back to the list of medications

Medication indications

OBIZUR 500 U powder and solvent for solution for injection

Treatment of bleeding episodes in patients with acquired haemophilia caused by antibodies to Factor VIII.

OBIZUR is indicated in adults.


Route of administration: Injectable
Molecule: antihaemophilic factor, porcine factor viii:c, susoctocog

Patients' opinions on Obizur

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.

Conditions related to this medication

Fact sheet

Haemophilia

See the fact sheet